Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo.
about
Augmenting the Efficacy of Immunotoxins and Other Targeted Protein Toxins by Endosomal Escape EnhancersSynergistic anticancer effects of the 9.2.27PE immunotoxin and ABT-737 in melanomaImmunotoxins: a promising treatment modality for metastatic melanoma?CypA, a gene downstream of HIF-1α, promotes the development of PDACCyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinomaPhase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporin.The MOC31PE immunotoxin reduces cell migration and induces gene expression and cell death in ovarian cancer cells.Bioinformatic prediction and experimental validation of a PE38-based recombinant immunotoxin targeting the Fn14 receptor in cancer cells.Tacrolimus and mycophenolate mofetil associations: Induction of oxidative stress or antioxidant effect?MOC31PE immunotoxin - targeting peritoneal metastasis from epithelial ovarian cancerCountering immunotoxin immunogenicity.Immunotoxin targeting EpCAM effectively inhibits peritoneal tumor growth in experimental models of mucinous peritoneal surface malignancies.Expression of FK506 binding protein 65 (FKBP65) is decreased in epithelial ovarian cancer cells compared to benign tumor cells and to ovarian epithelium.Novel Treatment with Intraperitoneal MOC31PE Immunotoxin in Colorectal Peritoneal Metastasis: Results From the ImmunoPeCa Phase 1 Trial.
P2860
Q26744722-FB03EE6F-60EA-48FC-B471-58BEC0AB9A4DQ28476828-F70A8FE1-FAC3-4180-A342-76378AA00604Q34986254-2366D6E9-2DCA-47FA-94C6-42C933814B53Q35129112-9A3735C9-BEEA-46D1-B8FC-AF85A6737043Q35213850-2FF7CA07-D992-4B4E-AC78-64272C12EB70Q36443899-84588BC3-36DC-4224-9A27-D2F969CBB860Q37597912-5A357B05-A324-474F-A42C-37BCF167DB94Q40267233-F4F94619-8567-43E8-8E8E-6C87E02352B1Q41488787-E34931CE-83A5-48C3-A4AB-1F3C2DCD0FB2Q42102343-52A17DA5-9FBE-4C40-A775-91B6F4109B7BQ42573903-0C712C7D-A4E8-489E-8559-5B75200AF681Q44556142-56BCCF97-70FE-4F85-A7AB-C164EA4AE511Q51493366-1EF7EA0B-432B-4C2F-BF46-90AC3BB2DEDDQ53487785-432D4FAC-6780-4092-8792-0868EC5B1E26
P2860
Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo.
@en
Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo.
@nl
type
label
Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo.
@en
Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo.
@nl
prefLabel
Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo.
@en
Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo.
@nl
P2093
P2860
P356
P1476
Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo.
@en
P2093
O Engebraaten
Y Andersson
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605312
P407
P577
2009-09-22T00:00:00Z